52.22. Analysis.
Comparison 52 Oral prostaglandin vs intravenous oxytocin: all women, unfavorable cervix, Outcome 22 Gastrointestinal effects.
Comparison 52 Oral prostaglandin vs intravenous oxytocin: all women, unfavorable cervix, Outcome 22 Gastrointestinal effects.